OSCR

Triacylglycerol metabolism is a novel target to combat West Nile virus infection.

Overview

  1. Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain
  2. Centro de Investigación en Sanidad Animal (CISA INIA-CSIC), Valdeolmos, Spain
  3. State Key Laboratory of Virology and Biosafety, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, People’s Republic of China
  4. Instituto de Quimica Medica (IQM, CSIC), Madrid, Spain
Journal: Emerging microbes & infections, volume 15, issue 1, article 2728216
Dates: published online 1 September 2026; in print December 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1080/22221751.2026.2728216 · PMID 42678221 · PMCID PMC13591993 · OpenAlex W7204913438
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Machine learning, Statistics, Smoothing, state filtering, decompositions
Keywords: West Nile virus, lipid, triacylglycerol, antiviral, neuroinflammation
MeSH: Antiviral Agents*, Triglycerides*, West Nile Fever*, West Nile virus*, Animals, Brain, Cytokines, Female, Humans, Lipid Droplets, Lipid Metabolism, Mice, Mice, Inbred C57BL, Mosquito-Borne Diseases, Virus Replication (* major topic)
Topic: Mosquito-borne diseases and control (Public Health, Environmental and Occupational Health, Medicine), according to OpenAlex
Funding: Ministerio de Ciencia e Innovación (PID2022-137372OR-C21, PID2022-137372OR-C22, TEC-2024/BIO-66/SALAINDEC-CM, CSIC's Global Health Platform (PTI Salud Global))
Citations: not cited yet (Europe PMC); 59 references in the paper

Abstract

West Nile virus (WNV) is a zoonotic Orthoflavivirus transmitted by mosquitoes that is responsible for outbreaks of meningitis and encephalitis worldwide. Driven by climate change, WNV has expanded as a global public health concern, particularly in temperate regions. However, there are still no specific approved therapies, reinforcing the need for antiviral development. Previous works have documented that WNV multiplication strictly depends on certain cellular lipids. To identify novel lipid-related therapeutic targets, we analyzed the infection-driven alterations in the CNS lipidome, the primary tissue supporting WNV replication. Our results indicated that the major alterations in the brain lipid content of WNV-infected mice corresponded to triacylglycerols (TAGs). Moreover, transcriptomic analysis showed that infected brains underwent changes in the expression of TAG metabolism. Supplementation with exogenous fatty acids increased lipid droplets (LD) content and promoted viral replication in cell culture models. On the contrary, pharmacological intervention in TAG metabolism using diacylglycerol acyltransferase inhibitors (DGATi) suppressed WNV multiplication in cell culture models. As a proof-of-concept of the therapeutic potential of DGATi, treatment of mice with A922500 reduced viral burden in the brain and proinflammatory cytokine production. Overall, our results unveil the importance of LDs and glycerolipid metabolism for WNV and highlight the potential of therapeutic interventions targeting this pathway to control viral replication and neuroinflammation.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Availability of data and materials

The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus repository under accession GSE310714.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 5 keywords, 15 MeSH terms, 1 funder, 58 references.

Cite

This paper

Caridi, F., Mingo-Casas, P., Esteban, A., Poderoso, T., de Oya, N. J., Calvo-Pinilla, E., Zhang, B., Priego, E.-M., Pérez-Pérez, M.-J., Blázquez, A.-B., & Martín-Acebes, M. A. (2026). Triacylglycerol metabolism is a novel target to combat West Nile virus infection. Emerging microbes & infections, 15(1), 2728216. https://doi.org/10.1080/22221751.2026.2728216

BibTeX

@article{caridi2026triacylglycerol,
author = {Caridi, Flavia and Mingo-Casas, Patricia and Esteban, Ana and Poderoso, Teresa and de Oya, Nereida Jiménez and Calvo-Pinilla, Eva and Zhang, Bo and Priego, Eva-María and Pérez-Pérez, María-Jesús and Blázquez, Ana-Belén and Martín-Acebes, Miguel A.},
title = {{Triacylglycerol metabolism is a novel target to combat West Nile virus infection}},
journal = {Emerging microbes \& infections},
year = {2026},
month = sep,
volume = {15},
number = {1},
pages = {2728216},
publisher = {Taylor \& Francis},
issn = {2222-1751},
doi = {10.1080/22221751.2026.2728216},
url = {https://doi.org/10.1080/22221751.2026.2728216},
pmid = {42678221},
pmcid = {PMC13591993}
}

RIS

TY - JOUR
AU - Caridi, Flavia
AU - Mingo-Casas, Patricia
AU - Esteban, Ana
AU - Poderoso, Teresa
AU - de Oya, Nereida Jiménez
AU - Calvo-Pinilla, Eva
AU - Zhang, Bo
AU - Priego, Eva-María
AU - Pérez-Pérez, María-Jesús
AU - Blázquez, Ana-Belén
AU - Martín-Acebes, Miguel A.
TI - Triacylglycerol metabolism is a novel target to combat West Nile virus infection
T2 - Emerging microbes & infections
J2 - Emerg Microbes Infect
PY - 2026
DA - 2026/09/18
VL - 15
IS - 1
SP - 2728216
SN - 2222-1751
PB - Taylor & Francis
DO - 10.1080/22221751.2026.2728216
UR - https://doi.org/10.1080/22221751.2026.2728216
LA - en
ER -

CSL-JSON

{
"id": "10.1080/22221751.2026.2728216",
"type": "article-journal",
"title": "Triacylglycerol metabolism is a novel target to combat West Nile virus infection",
"container-title": "Emerging microbes & infections",
"author": [
{
"family": "Caridi",
"given": "Flavia"
},
{
"family": "Mingo-Casas",
"given": "Patricia"
},
{
"family": "Esteban",
"given": "Ana"
},
{
"family": "Poderoso",
"given": "Teresa"
},
{
"family": "de Oya",
"given": "Nereida Jiménez"
},
{
"family": "Calvo-Pinilla",
"given": "Eva"
},
{
"family": "Zhang",
"given": "Bo"
},
{
"family": "Priego",
"given": "Eva-María"
},
{
"family": "Pérez-Pérez",
"given": "María-Jesús"
},
{
"family": "Blázquez",
"given": "Ana-Belén"
},
{
"family": "Martín-Acebes",
"given": "Miguel A."
}
],
"container-title-short": "Emerg Microbes Infect",
"volume": "15",
"issue": "1",
"page": "2728216",
"DOI": "10.1080/22221751.2026.2728216",
"PMID": "42678221",
"PMCID": "PMC13591993",
"ISSN": "2222-1751",
"publisher": "Taylor & Francis",
"URL": "https://doi.org/10.1080/22221751.2026.2728216",
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
18
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12974-023-02899-3
Glycolytic shift during West Nile virus infection provides new therapeutic opportunities.
Journal: Journal of neuroinflammation
In common: other condition, mouse, cellular / molecular, 6 references, 4 authors
[2] doi:10.1002/advs.202505844
Metabolic Programming Drives Protective and Inflammatory Monocyte Fates in Viral Encephalitis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: other condition, mouse, cellular / molecular, 3 references
[3] doi:10.1371/journal.ppat.1011350 [code]
Oligodendrocyte-derived IL-33 functions as a microglial survival factor during neuroinvasive flavivirus infection.
Journal: PLoS pathogens
In common: other condition, mouse, cellular / molecular, 2 references
[4] doi:10.1038/s41467-026-70281-x [code]
A human cerebral organoid model of West Nile virus encephalitis shows innate immunocompetency.
Journal: Nature communications
In common: other condition, cellular / molecular, 2 references
[5] doi:10.1186/s13073-022-01111-0
Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination.
Journal: Genome medicine
In common: mouse, cellular / molecular, 2 references
[6] doi:10.1038/s41467-025-63243-2 [code]
Spatial isotope deep tracing deciphers inter-tissue metabolic crosstalk.
Journal: Nature communications
In common: other condition, mouse, cellular / molecular, 1 reference
[7] doi:10.3390/ijms252212231
Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers.
Journal: International journal of molecular sciences
In common: other condition, mouse, cellular / molecular, 1 reference
[8] doi:10.1080/22221751.2022.2156815
Differential effects of Usutu and West Nile viruses on neuroinflammation, immune cell recruitment and blood-brain barrier integrity.
Journal: Emerging microbes & infections
In common: other condition, mouse, cellular / molecular, 1 reference
[9] doi:10.1186/s12974-025-03471-x
Temporally resolved single-cell RNA sequencing reveals protective and pathological responses during herpes simplex virus CNS infection.
Journal: Journal of neuroinflammation
In common: other condition, mouse, cellular / molecular, 1 reference
[10] doi:10.1038/s41598-021-99696-w
Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West Nile virus infection.
Journal: Scientific reports
In common: other condition, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.